secukinumabinterleukin (IL)-17ADisease Activity Score 28Health Assessment QuestionnairePsoriatic ArthritisPsAPsAMRIS
…al bone damage over 48 months in patients with PsA treated with secukinumab, suggesting that anti-IL-17A therapy induces sustained osteopro…